Navivumab Biosimilar - Anti-hemagglutinin HA mAb - Research Grade
Source
CAS 1443004-16-7
Species
Homo sapiens
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Navivumab,CT-P23,hemagglutinin HA,anti-hemagglutinin HA
Reference
PX-TA1384
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG1-kappa
Clonality
Monoclonal Antibody
Description of Navivumab Biosimilar - Anti-hemagglutinin HA mAb - Research Grade
General information on Anti-Influenza A virus hemagglutinin HA[Influenza A virus] (Navivumab) Monoclonal Antibody
Navivumab is investigated for the treatment of Influenza. It blocks HA-mediated membrane fusion, thereby inhibiting the entry of influenza virus into host cells.
Reviews
There are no reviews yet.